Features | Partner Sites | Information | LinkXpress
Sign In
PZ HTL SA
GLOBETECH PUBLISHING
GLOBETECH PUBLISHING

Differential Production of Amyloid Proteins Marks Hereditary Alzheimer's Disease

By BiotechDaily International staff writers
Posted on 24 Jun 2013
Alzheimer's disease (AD) researchers employing SILK (stable isotope linked kinetics) technology have shown that individuals with a hereditary form of AD overproduce type 42 amyloid beta protein, which readily accumulates in the amyloid plaques that characterize the disease.

Most cases of Alzheimer's disease are not hereditary. However, there is a small subset of cases that have an earlier age of onset and a strong genetic element. In patients suffering from this form of Alzheimer's disease (autosomal dominant hereditary), mutations in the presenilin proteins (PSEN1 and PSEN2) or the amyloid precursor protein (APP) can be found. The majority of these cases carry mutant presenilin genes. An important factor in the disease process in AD is the accumulation of amyloid beta (Abeta) protein. To form Abeta, APP must be cut by two enzymes, beta secretases and gamma secretase. Presenilin is the sub-component of gamma secretase that is responsible for the cutting of APP.

Until the development of SILK, there was no method to directly measure the production or clearance of Abeta. The SILK technique, which was first described in 2006, requires 36 hours to perform, but is the only published method that allows measurement of amyloid plaque formation and clearance in the living brain.

Investigators at Washington University School of Medicine (St. Louis, MO, USA) recently used SILK technology to evaluate 11 subjects with Alzheimer’s mutations and compare the findings to those obtained from 12 related family members who did not have Alzheimer’s mutations.

Results revealed that the AD patients synthesized about 20% more Abeta42 than did family members who lacked the Alzheimer’s mutation. The fractional turnover rate of soluble Abeta42 relative to another form of amyloid protein Abeta40 was 65% faster in mutation carriers and correlated with amyloid deposition, consistent with increased deposition of Abeta42 into plaques, leading to reduced recovery of Abeta42 in cerebrospinal fluid (CSF).

“These results indicate how much we should target amyloid beta 42 with Alzheimer’s drugs,” said senior author Dr. Randall Bateman, professor of neurology at Washington University School of Medicine. “We are hopeful that this and other research will lead to preventive therapies to delay or even possibly prevent Alzheimer’s disease.”

The study was published in the June 12, 2013, issue of the journal Science Translational Medicine.

Related Links:
Washington University School of Medicine




Channels

Drug Discovery

view channel
Image: Chitosan is derived from the shells of shrimp and other sea crustaceans, including Alaskan pink shrimp, pictured here (Photo courtesy of NOAA - [US] National Oceanic and Atmospheric Administration).

Chitosan Treatment Clears the Way for Antibiotics to Eliminate Recurrent Urinary Tract Infections

Recurrent urinary tract infection was successfully resolved in a mouse model by treatment with the exfoliant chitosan followed by a round of antibiotics. Bacterial urinary tract infection (UTI), most... Read more

Biochemistry

view channel

Mitochondrial Cause of Aging Can Be Reversed

Researchers have found a cause of aging in lab animals that can be reversed, possibly providing an avenue for new treatments for age-related diseases including type 2 diabetes, cancer, muscle wasting, and inflammatory diseases. The researchers plan to begin human trials late 2014. The study, which was published December... Read more

Therapeutics

view channel

Cytokine Identified That Causes Mucositis in Cancer Therapy Patients

The action of the cytokine interleukin 1-beta (IL-1beta) has been found to underlie the onset of mucositis, a common, severe side effect of chemotherapy and irradiation of cancer patients. Mucositis occurs as a result of cell death in reaction to chemo- or radiotherapy. The mucosal lining of the mouth becomes thin, may... Read more

Business

view channel

Analytical Sciences Trade Fair Declared a Rousing Success

Organizers of this year's 24th "analytica" biosciences trade fair have reported significant increases in both the number of visitors and exhibitors compared to the 2012 event. The analytica trade fair for laboratory technology, analysis, and biotechnology has been held at the Munich (Germany) Trade Fair Center every... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.